Pioneering prescription digital therapeutics
Reversing insulin resistance with AI-driven lifestyle modification.
Get in touch
Our purpose
Empowering people to restore their cardiometabolic health.
1 in 3 adults suffers from more than one chronic condition. We create digital therapies that treat the cause, not the symptoms. One habit at a time. Without side effects.
Robust DTx platform with a human touch
Personalised therapy
Building healthy habits via smart nudges and personalised goals. We combine evidence-based content and complex user data to provide daily engaging guidance.
AI-driven real-time feedback
Our proprietary AI model provides real-time diet feedback and recommendations. Just like a human dietitian but anywhere and anytime the user needs it.
Proactive human support
Support and guidance whenever the user needs it. Whether it is sharing experiences with others in the in-app social network or proactive support of a personal dietitian.
Exceptional engagement rate proven by thousands of users
Clinically proven outcomes
We are committed to the highest scientific standards. Multiple independent studies, published in peer-reviewed journals, confirm the clinical effectiveness of Vitadio.
The 6-month HbA1c reduction is comparable to modern antidiabetic medications
of patients report a significant body weight reduction
Significantly more patients achieve their therapy goals. With Vitadio, 3.3 times more patients reached their target HbA1c (<7%) compared to standard care.
Bretschneider et al., 2025Vitadio delivers weight reduction comparable to intensive in-person obesity interventions and demonstrates positive effects across multiple components of the metabolic syndrome.
Moravcová et al., 2024
University Olomouc
Vitadio helps patients achieve stronger self-management in nutrition and physical activity while significantly reducing diabetes-related distress.
Bretschneider et al., 2022(see also Bretschneider et al. (2025) above)
Vitadio promotes healthy weight loss by reducing body fat while preserving muscle mass, leading to improved body composition.
Moravcová et al., 2022University Olomouc
The biggest pharmaceutical players augment their pharmacotherapy with Vitadio
What are the benefits of combining medication with digital therapeutics?
- Achieving a superior reduction in HbA1c and body weight
- Improving quality of life
- Driving better adherence to treatment
- Providing differentiation in the market
How it started
Our story began in 2019 when our 4 founders decided to innovate type 2 diabetes care and provide best-in-class therapy by combining the power of artificial intelligence and evidence-based medicine.
Today, Vitadio, with headquarters in Prague and Berlin, offers digital therapeutics for type 2 diabetes and prediabetes across three European countries, with ongoing expansion efforts.
Featured in
Join our purpose-driven team that tackles the biggest challenges in healthcare.